(Q34338001)

1 August 2017

1 reference

title

Peroxisome proliferators: their biological and toxicological effects (English)

1 reference

1 August 2017

S Dzhekova-Stojkova

1

1 reference

1 August 2017

J Bogdanska

series ordinal

2

1 reference

1 August 2017

Z Stojkova

series ordinal

3

1 reference

1 August 2017

publication date

1 June 2001

1 reference

Clinical Chemistry and Laboratory Medicine

1 August 2017

published in

1 reference

1 August 2017

volume

39

1 reference

1 August 2017

issue

6

1 reference

1 August 2017

page(s)

468-474

1 reference

A fatty acyl-CoA oxidizing system in rat liver peroxisomes; enhancement by clofibrate, a hypolipidemic drug

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.076

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.076

On the role of the peroxisome in the metabolism of drugs and xenobiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.076

Mechanisms of hepatocarcinogenicity of peroxisome-proliferating drugs and chemicals

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.076

Review of the hepatic response to hypolipidaemic drugs in rodents and assessment of its toxicological significance to man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.076

Chemically induced proliferation of peroxisomes: implications for risk assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.076

Transcription regulation of peroxisomal fatty acyl-CoA oxidase and enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase in rat liver by peroxisome proliferators

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.076

Biochemical mechanisms of induction of hepatic peroxisome proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.076

Hepatic peroxisome proliferation in rodents and its significance for humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.076

Interaction of some peroxisome proliferators with the mouse liver peroxisome proliferator-activated receptor (PPAR): a molecular modelling and quantitative structure-activity relationship (QSAR) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.076

Identification of cytosolic peroxisome proliferator binding protein as a member of the heat shock protein HSP70 family

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.076

Peroxisome proliferator-activated receptors: finding the orphan a home

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.076

Differential expression and activation of a family of murine peroxisome proliferator-activated receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.076

Identification of two mPPAR related receptors and evidence for the existence of five subfamily members

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.076

Induction of the peroxisome proliferator activated receptor by fenofibrate in rat liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.076

Xenopus peroxisome proliferator activated receptors: genomic organization, response element recognition, heterodimer formation with retinoid X receptor and activation by fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.076

cDNA cloning, chromosomal mapping, and functional characterization of the human peroxisome proliferator activated receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.076

Microsomal cytochrome P-452 induction and peroxisome proliferation by hypolipidaemic agents in rat liver. A mechanistic inter-relationship

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.076

Carcinogenesis by Hepatic Peroxisome Proliferators: Evaluation of the Risk of Hypolipidemic Drugs and Industrial Plasticizers to Humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.076

Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.076

Identification of a new member of the steroid hormone receptor superfamily that is activated by a peroxisome proliferator and fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.076

Hydrogen peroxide generation in peroxisome proliferator-induced oncogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.076

Cell death by apoptosis and its protective role against disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.076

Peroxisome proliferator-activated receptor (PPAR) alpha activation and its consequences in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.076

Comparison of the effects of various peroxisome proliferators on peroxisomal enzyme activities, DNA synthesis, and apoptosis in rat and human hepatocyte cultures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.076

21 January 2018

Identifiers

DOI

10.1515/CCLM.2001.076

1 reference

1 August 2017

1 reference